LNCaP RNA-seq
LNCaP RNA-seq libraries were prepared as described in ref. 3 . In brief, LNCaP poly(A) + RNA was extracted with FastTrack MAG Maxi mRNA Isolation Kit (Invitrogen), as per manufacturer's protocol, treated with 25 U of DNase I, Amplification Grade (Invitrogen) for 1 h at room temperature, quantified with Quant-iT RiboGreen RNA Reagent (Invitrogen) and assessed for integrity on 2100 Bioanalyzer (Agilent). Obtained RNA samples were used for strand-specific paired-end RNA-seq library preparation, in accordance with the standard illumina protocol and two biological replicates were sequenced on a HiSeq 2000. Data were processed as described in the main text, and 298.37 million read pairs were successfully mapped to human genome assembly hg19.
5ʹ and 3ʹ rapid amplification of cDNA ends (RACE)
Human Prostate Marathon-Ready cDNA (Clontech) was used to validate strand-specific RNA-seq identification of HIPSTR in LNCaP prostate carcinoma cell line. The first round of the 5ʹ and 3ʹ
RACE PCRs was done in complete agreement with Marathon-Ready cDNA library user manual (Clontech). The second round of RACE PCR was performed with nested strand-specific primers to increase the specificity of target product detection (Table S11 ). Obtained PCR products were gelpurified (Wizard SV Gel and PCR Clean-Up System; Promega), cloned into pGEM T-Easy vector (Promega), and sequenced.
HIPSTR coding potential analysis and polyadenylation signal prediction
To assess HIPSTR coding potential, we first searched for potential open reading frames (ORFs)
within HIPSTR gene sequence by using the ORF Finder on-line tool (http://www.ncbi.nlm.nih.gov/gorf/gorf.html). To screen for similarities with any known proteins, all found ORFs were then subjected to blastp search against Non-redundant (nr) protein sequences database (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins).
ORF shuffling was done essentially as described in ref. 4 . Briefly, HIPSTR sequence was split into groups of 3 nucleotides, which were subsequently shuffled 1000 times. Considering only ORFs that begin with a canonical ATG start codon, maximum ORF sizes were retrieved after each shuffling, and their distribution was plotted. ORF sizes are expressed as fractions of HIPSTR length.
HCpolya, Hamming Clustering poly-A prediction in Eukaryotic Genes on-line tool (http://bioinfo4.itb.cnr.it/~webgene/wwwHC_polya.html) with pattern length parameter set at 12 was used to predict HIPSTR polyadenylation signal position 5 . 
RNA extraction, cDNA synthesis, and quantitative PCR (qPCR)
Total RNA was extracted with TRIzol (Invitrogen) and purified with RNeasy Micro Kit (QIAGEN)
according to manufacturer's protocol, with on-column DNAse I treatment time extended to 1 h. Total RNA was quantified on ND-1000 (NanoDrop), and its integrity was checked with 2100 Bioanalyzer (Agilent). Total RNA was reverse transcribed with SuperScript III First-Strand Synthesis System (Invitrogen) and oligo(dT) 20 primer for detection of any transcript mentioned in this study, except for HIPSTR. To detect human HIPSTR, 100 to 500 ng total RNA and 20 pmol of strand-specific Primer #1 (Table S11) were annealed at 60 °C for 5 min, and cDNA was then synthesized at 55 °C for 1 h with ImProm-II Reverse Transcription System (Promega) and Mg 2+ concentration of 6 mM. To detect mouse Hipstr, 1 μg total RNA and 20 pmol of strand-specific Primer #2 (Table S11) were annealed at 62.5 °C for 5 min, and cDNA was then synthesized at 50 °C for 1 h with ImProm-II Reverse Transcription System (Promega) and Mg 2+ concentration of 6 mM. Strand-specific primers #1 and #2 contained a tag sequence (ATGGCGAGAATCAATGCG) at the 5ʹ-end that has no complementarity to the human or mouse genome. This tag sequence served as a target for annealing of the reverse qPCR primer, ensuring the strand specificity and eliminating non-specific background amplification 7 in the human or mouse HIPSTR detection assays. ng/ml EGF (Sigma), 5 μg/ml bovine insulin (Sigma) and 1x Glutamax-I supplement (Invitrogen).
Medium was changed every other day. After six-seven days of differentiation, resultant neuroepithelial spheres attached and gave rise to migratory hNCCs, as previously described 10 . Fourfive days after the appearance of the first hNCCs, cells were collected for subsequent analyses.
H1 BP cells culture and derivation of human trophoblast-like cells (hTBCs) in vitro
H1 BP cells were derived from H1 hESCs (WiCell), cultured and differentiated into hTBCs as described previously 2 . Briefly, H1 BP cells were maintained in the hESC basal medium 11, 12 , which had been conditioned by a monolayer of γ-irradiated mouse embryonic fibroblast (MEF) feeder cells for 24 h, and then supplemented with 10 ng/ml FGF2. Medium was changed every day. 
TFAP2A protein and HIPSTR lncRNA transient ectopic overexpression
Full-length HIPSTR sequence was amplified from HEK293 genomic DNA with KpnI-FL-HIPSTR-F
and HindIII-FL-HIPSTR-R primers (Table S11 ) and cloned into pCEP4 vector (Invitrogen) between
KpnI and HindIII sites.
Approximately 5x10 5 HEK293 cells were transfected with 3 μg of pCEP4-HIPSTR or pCEP4 empty vector for HIPSTR overexpression assays, or pcDNA3-TFAP2A-1a, pcDNA3-TFAP2A-1b, pcDNA3-TFAP2A-1c, or pcDNA3 empty vector for TFAP2A overexpression assays; pcDNA3-TFAP2A-1a, pcDNA3-TFAP2A-1b, and pcDNA3-TFAP2A-1c expression vectors used for TFAP2A isoforms overexpression were kindly provided by Dr. Chiara Berlato (Queen Mary University of London, London, UK). Cells were collected for RNA and protein extraction 72 h after transfection.
Transfections were carried out by using FuGENE HD Reagent (Promega) at 3:1 transfection reagent:DNA ratio in the corresponding complete growth media.
Dual-luciferase assays
By using H3K4me3 ChIP-seq peaks from ENCODE Project as a guideline, HIPSTR candidate promoter sequences were amplified from HEK293 genomic DNA and cloned into pGL3-Basic vector (Promega) between KpnI and NheI sites. Inserts were generated as follows: for pGL3-P1 the insert was generated with KpnI-promoter-primer-A and NheI-promoter-primer-G, for pGL3-P2 -with KpnI-promoter-primer-A and NheI-promoter-primer-E, for pGL3-P3 -with KpnI-promoterprimer-F and NheI-promoter-primer-G, for pGL3-P4 -with KpnI-promoter-primer-H and NheIpromoter-primer-B, for pGL3-P5 -with KpnI-promoter-primer-F and NheI-promoter-primer-B, for pGL3-P6 -with KpnI-promoter-primer-A and NheI-promoter-primer-B, and for pGL3-P7 -with
NheI-promoter-primer-C and KpnI-promoter-primer-D (Table S11) In the overexpression assays of TFAP2A isoforms, 800 ng of TFAP2A-overexpressing plasmid were co-transfected with luciferase genes-carrying constructs at transfection reagent:DNA ratio 1.5:1.
Firefly luciferase activity in the lysates of the cells transfected with 3xAP2-Bluc plasmid served as a positive control for TFAP2A transactivation activity. 3xAP2-Bluc plasmid was a kind gift from Dr.
Trevor Williams (University of Colorado Denver, Aurora, USA).
Promoter 
Western blot analysis
For western blot analysis, collected cells were washed twice with ice-cold PBS, resuspended in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1 % SDS, 0.5 % sodium deoxycholate, 1 % Triton X-100, 1mM EDTA), and sonicated. Protein content of the lysates was quantified with Micro BCA Protein Assay Kit (Thermo Fisher Scientific). Equal protein amounts (40 µg) were resolved on 12 % SDS-polyacrylamide gel, transferred onto nitrocellulose membranes (Amersham Biosciences) and processed with standard methods 15 . Primary antibodies were anti-TFAP2A (Santa Cruz, sc12726)
(1:100), and anti-Actin (Millipore, MAB1501) (1:5000). Secondary antibody was goat anti-Mouse IgG, Alexa Fluor® 680 conjugate (Thermo Fisher Scientific) (1:10000). Supplementary Data: Tables S1 to S11 (XLS files) : Table S1 , List of genes differentially expressed in HEK293 cells after HIPSTR knockdown (q-value < 0.01, |log 2 (fold-change)| > 1); Table S2 , List of genes differentially expressed -both in H1 BP cells and HEK293 -after HIPSTR knockdown (q-value < 0.01, |log 2 (fold-change)| > 1); Table S3 , Genes differentially expressed in H1 BP cells after HIPSTR knockdown (q-value < 0.01, Table S9 , Counts of all expressed (> 3 FPKM) and analyzed genes (3 -30 FPKM) from the singlecell RNA-seq data sets used in this study (see above); Table S10 , lncRNAs used in Cabili et al., 2015, and detected as expressed (>3 FPKM) in at least one cell from at least one single-cell RNA-seq data set analyzed in the current study Table S11 , Sequences of the oligonucleotides used in this study. Z02  Z03  Z04  Z05  Z06  Z07  Z08  Z09   2C E01  2C E02  2C E03  2C E04  2C E05  2C E06  2C E07  2C E08  2C E09  2C E10  4C E01  4C E02  4C E03  4C E04  4C E05  ICM E01  ICM E02  ICM E03  ICM E04  TE E01  TE E02  TE 
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